Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution - Garcia-Donas, J.; Martínez-Urbistondo, D.; Velázquez Kennedy, K.; Villares, P.; Barquin, A.; Dominguez, A.; Rodriguez-Moreno, J.F.; Caro, E.; Suarez del Villar, R.; Nistal-Villan, E.; Yagüe, M.; Ortiz, M.; et al. (Frontiers in Immunology, 2023)